Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and ...
New statistics show Britain has the highest cases of esophageal cancer in the entire Europe, mostly for those under 40 years ...
Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, ...
A family owned company is doing what they can to help an employee who is fighting esophageal cancer. Jesse Porter started in ...
Topline data were announced from a phase 3 trial evaluating Keytruda plus Lenvima with chemotherapy in advanced gastroesophageal cancer.
Turns out, he had advanced cancer of the esophagus. Upon the diagnosis, a doctor at Memorial Sloan Kettering Cancer Center in New York told Frazzitta there was good news and bad news. The good ...